SEC Form 8-K Summary
Registrant: Brilliant Acquisition Corporation, not T3 Defense Inc. The report was filed February 23, 2023, under Items 1.01, 2.03, 7.01 and 9.01. Brilliant is a special purpose acquisition company incorporated in the British Virgin Islands.
Business Context and Reporting Period
The filing concerns Brilliant’s proposed business combination with Nukkleus, Inc. Under the merger agreement, Merger Sub would merge into Brilliant, with Brilliant becoming a wholly owned subsidiary of Nukkleus. The filing is not a periodic financial report and does not provide operating results for a comparable reporting period.
Key Financial and Capital Structure Matters
- Brilliant issued Nukkleus an unsecured, non-interest-bearing promissory note with a principal amount of $32,500 on February 23, 2023.
- The note matures upon closing of Brilliant’s initial business combination.
- If no business combination is completed, repayment is limited to amounts remaining outside Brilliant’s trust account, if any.
- Note proceeds were deposited into Brilliant’s trust account in connection with extending the business-combination completion deadline.
- The filing provides no revenue, profit, cash-flow, margin, debt-balance, liquidity, or other operating metrics beyond the note described above.
Material Changes and Outlook
- Brilliant extended its deadline to complete an initial business combination by one month, from the prior deadline to March 23, 2023.
- The extension was supported by the $32,500 note funded by Nukkleus.
- The proposed Nukkleus transaction remained subject to shareholder approvals, regulatory approvals, satisfaction of transaction conditions and minimum trust-account requirements after any shareholder redemptions.
Risks, Contingencies and Unusual Items
- The proposed business combination may not close by the extended deadline or may not close at all.
- Failure to complete a transaction could result in repayment of the note only from funds outside the trust account, if any.
- Completion depends on shareholder approvals, minimum trust-account proceeds after redemptions, governmental and regulatory approvals, and other customary closing conditions.
- The filing identifies risks involving redemption levels, Nasdaq listing, litigation, regulatory changes, market volatility, employee retention, business disruption and the ability to execute post-combination plans.
- The press release furnished under Item 7.01 is not treated as filed for purposes of Section 18 of the Exchange Act, except as otherwise specified.
Investor Verification Checklist
- Verify the current status of the Nukkleus-Brilliant merger, including whether it closed or was terminated.
- Review the full $32,500 promissory note and its repayment provisions.
- Confirm the amount remaining in Brilliant’s trust account and any shareholder redemptions.
- Review the applicable proxy statement/prospectus, registration statement and subsequent SEC filings for updated transaction conditions and risks.
- Confirm Brilliant’s business-combination deadline and any later extensions or liquidation actions.